The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study

Pituitary. 2024 Aug;27(4):416-427. doi: 10.1007/s11102-024-01403-1. Epub 2024 Jun 7.

Abstract

Purpose: Cardiac abnormalities are common in patients with acromegaly, contributing to the increased morbidity and mortality. Cardiac magnetic resonance (CMR) is the gold standard for measuring cardiac morpho-functional changes. This study aims to detect cardiac alterations in acromegaly through CMR, even when the disease is adequately controlled.

Methods: In this, multicentre, case-control study, we compared consecutive patients with acromegaly, cured after surgery or requiring medical treatment, with matched controls recruited among patients harbouring non-functioning adrenal incidentalomas.

Results: We included 20 patients with acromegaly (7 females, mean age 50 years) and 17 controls. Indexed left ventricular-end-diastolic volume (LV-EDVi) and LV-end-systolic volume (LV-ESVi) were higher in patients than in controls (p < 0.001), as were left ventricular mass (LVMi) (p = 0.001) and LV-stroke volume (LV-SVi) (p = 0.028). Right ventricle (RV) EDVi and ESVi were higher, whereas RV-ejection fraction (RV-EF) was lower (p = 0.002) in patients than in controls (p < 0.001). No significant differences were observed in the prevalence of cardiometabolic comorbidities, including hypertension, glucose and lipid metabolism impairment, obstructive sleep apnoea syndrome, and obesity. IGF1 x upper limit of normal significantly predicted LVMi (b = 0.575; p = 0.008). Subgroup analysis showed higher LVMi (p = 0.025) and interventricular septum thickness (p = 0.003) in male than female patients, even after adjusting cardiac parameters for confounding factors.

Conclusions: The CMR analysis reveals a cluster of biventricular structural and functional impairment in acromegaly, even when the biochemical control if achieved. These findings appear specifically triggered by the exposure to GH-IGF1 excess and show sex-related differences advocating a possible interaction with sex hormones in cardiac disease progression.

Keywords: Acromegaly; Cardiac magnetic resonance; Cardiomyopathy; Growth hormone; IGF1; Myocardial hypertrophy.

Publication types

  • Multicenter Study

MeSH terms

  • Acromegaly* / complications
  • Acromegaly* / diagnostic imaging
  • Acromegaly* / pathology
  • Adult
  • Aged
  • Case-Control Studies
  • Female
  • Heart / diagnostic imaging
  • Heart / physiopathology
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Middle Aged